BTIG Research restated their neutral rating on shares of Agilon Health (NYSE:AGL – Free Report) in a research note published on Friday,Benzinga reports. Several other equities research analysts also recently issued reports on the company. Weiss Ratings restated a “sell (e+)” rating on shares of Agilon Health in a research report on Wednesday, October 8th. […]